Publication | Closed Access
A Novel Orally Active Inverse Agonist of Estrogen-related Receptor Gamma (ERRγ), DN200434, A Booster of NIS in Anaplastic Thyroid Cancer
50
Citations
24
References
2019
Year
DN200434 shows potential clinical applicability for diagnosis and treatment of ATC or other poorly differentiated thyroid cancers.
| Year | Citations | |
|---|---|---|
Page 1
Page 1